Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/YB4P stock hub

FRA/YB4P has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/YB4Pis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/YB4PFRA/YB4P

—

Loading chart…

In the news

Latest news · FRA/YB4P

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-63.5

P25 n/aP50 n/aP75 n/a

ROIC-35.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/YB4P market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

141

Groups with data

Currency

USD

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	70
Employees Change	11%
Employees Change Percent	18.64
Enterprise value	EUR 951.3M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 1.1B
Price	EUR 4.34
Price currency	EUR
Sic	2834
Symbol	fra/YB4P
Website	https://www.savarapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.98%
EV Earnings	-9.4x
EV/FCF	-11.05x
FCF yield	-7.64%
P/B ratio	6.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -69.3M
Net Income	EUR -101.2M
Profit Per Employee	EUR -1.4M
ROA	-32.91
Roa5y	-24.51
ROCE	-52.68
ROE	-63.45
Roe5y	-48.09
ROIC	-35.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	60.72%
Cagr3y	34.06%
Cagr5y	26.11%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 215.9M
Cash	EUR 201.5M
Current Assets	EUR 204.9M
Current Liabilities	EUR 17.3M
Debt	EUR 25.5M
Debt Equity	EUR 0.15
Debt FCF	EUR -0.3
Equity	EUR 173M
Liabilities	EUR 42.8M
Long Term Assets	EUR 11M
Long Term Liabilities	EUR 25.5M
Net Cash	EUR 176M
Net Cash By Market Cap	EUR 15.62
Net Cash Growth	21.61%
Net Debt Equity	EUR -1.02
Tangible Book Value	EUR 163.1M
Tangible Book Value Per Share	EUR 0.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.85
Net Working Capital	EUR -13.1M
Quick ratio	11.66
Working Capital	EUR 188.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	60.67%
200-day SMA	4
3Y total return	141%
50-day SMA	4.6
50-day SMA vs 200-day SMA	50over200
5Y total return	218.97%
All Time High	14.09
All Time High Change	-69.2%
All Time High Date	2017-12-20
All Time Low	0.64
All Time Low Change	583.15%
All Time Low Date	2019-11-15
ATR	0.14
Ch YTD	-18.15
High	4.34
High52	5.9
High52 Date	2025-12-12
High52ch	-26.47%
Low	4.31
Low52	1.66
Low52 Date	2025-05-27
Low52ch	161.33%
Ma50ch	-5.59%
Price vs 200-day SMA	8.37%
RSI	44.8
RSI Monthly	56.92
RSI Weekly	50.42
Sharpe ratio	1.05x
Sortino ratio	1.59
Total Return	-12.21%
Tr YTD	-18.15
Tr1m	-11.65%
Tr1w	-3.39%
Tr3m	-2.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -104.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	130,160,571%
Net Borrowing	2,008,822
Shares Insiders	2.12%
Shares Institutions	54.12%
Shares Qo Q	11.02%
Shares Yo Y	12.21%
Short Ratio	17.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -98.4M
Average Volume	0x
Bv Per Share	0.68
CAPEX	EUR -18,737
Ch1m	-11.65
Ch1w	-3.39
Ch1y	60.67
Ch3m	-2.3
Ch3y	141
Ch5y	219
Ch6m	27.59
Change	-1.48%
Change From Open	0.58
Close	4.4
Days Gap	-2.04
Depreciation Amortization	73,772.7
Earnings Date	2026-05-13
EBIT	EUR -104.6M
EBITDA	EUR -104.5M
EPS	EUR -0.46
F Score	1
FCF	EUR -86.1M
FCF EV Yield	-9.05x
Financing CF	117,369,370
Fiscal Year End	December
Founded	2,007
Investing CF	-15,705,348
Is Primary Listing	0
Last Report Date	2025-12-31
Ma150	4.44
Ma150ch	-2.39%
Ma20	4.51
Ma20ch	-3.9%
Net CF	15,374,888
Next Earnings Date	2026-05-13
Open	4.31
Position In Range	100
Ppne	84,796.2
Price Date	2026-05-08
Ptbv Ratio	6.91
Relative Volume	20x
Share Based Comp	12,282,366
Tr6m	27.59%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/YB4P pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/YB4P stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/YB4P?

Insider, institutional, and short-interest positioning.

Institutional ownership

+54.1%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/YB4P momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.8

Neutral momentum band

Price vs 200-day MA

+8.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/YB4P

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/YB4P stock rating?

fra/YB4P is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/YB4P analysis?

The full report lives at /stocks/fra/YB4P/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/YB4P?

The latest report frames fra/YB4P around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/YB4P page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.